Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment
Clinical trial NCT03196206 · COMPLETED
Trial details
- NCT number
- NCT03196206
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-13
- Primary completion
- 2018-03-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.